We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-3.74%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$309B
AUM Growth
-$29.4B
(-8.7%)
Cap. Flow
-$6.3B
Cap. Flow
% of AUM
-2.04%
Top 10 Holdings %
Top 10 Hldgs %
22.53%
Holding
3,477
New
138
Increased
1,588
Reduced
1,481
Closed
89
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$949M |
| 2 |
EOG Resources
EOG
|
+$470M |
| 3 |
Mastercard
MA
|
+$453M |
| 4 |
Las Vegas Sands
LVS
|
+$413M |
| 5 |
Booking.com
BKNG
|
+$413M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$712M |
| 2 |
Meta Platforms (Facebook)
META
|
+$565M |
| 3 |
PayPal
PYPL
|
+$556M |
| 4 |
Morgan Stanley
MS
|
+$541M |
| 5 |
Pfizer
PFE
|
+$388M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.81% |
| 2 | Financials | 12.45% |
| 3 | Healthcare | 12.44% |
| 4 | Consumer Discretionary | 11.85% |
| 5 | Industrials | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Spyre Therapeutics
SYRE
$9.25B
| $425K | ﹤0.01% |
6,765
+12
| +0.2% | +$1.01K |
|
|
PRTK
3027
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $425K | ﹤0.01% |
133,751
+1,002
| +0.8% | +$3.77K |
|
3028
NN Inc
NNBR
$291M
| $422K | ﹤0.01% |
146,966
-33,721
| -19% | -$111K |
|
3029
Vor Biopharma
VOR
$1.28B
| $422K | ﹤0.01% |
2,765
+53
| +2% | +$9.02K |
|
3030
Cytosorbents Corp
CTSO
$22.6M
| $420K | ﹤0.01% |
135,134
+1,137
| +0.8% | +$4.07K |
|
|
IGMS
3031
DELISTED
IGM Biosciences
IGMS
| $420K | ﹤0.01% |
26,412
+2,530
| +11% | +$47.1K |
|
3032
TherapeuticsMD
TXMD
$24M
| $419K | ﹤0.01% |
21,234
| – | – |
|
|
MILE
3033
DELISTED
Metromile, Inc. Common Stock
MILE
| $417K | ﹤0.01% |
338,963
+122,600
| +57% | +$177K |
|
3034
ClearPoint Neuro
CLPT
$433M
| $416K | ﹤0.01% |
44,545
| – | – |
|
|
LBC
3035
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $414K | ﹤0.01% |
30,683
+343
| +1% | +$4.6K |
|
3036
Energy Transfer Partners
ET
$69.3B
| $408K | ﹤0.01% |
41,200
-786
| -2% | -$7.79K |
|
3037
Zevia
ZVIA
$111M
| $402K | ﹤0.01% |
99,199
+88,542
| +831% | +$616K |
|
|
ATHX
3038
DELISTED
Athersys, Inc. Common Stock
ATHX
| $395K | ﹤0.01% |
22,274
+149
| +0.7% | +$3.12K |
|
3039
Janux Therapeutics
JANX
$967M
| $392K | ﹤0.01% |
25,660
+6,203
| +32% | +$101K |
|
|
DAWN
3040
DELISTED
Day One Biopharmaceuticals
DAWN
| $391K | ﹤0.01% |
39,774
+24,813
| +166% | +$328K |
|
3041
Global Water Resources
GWRS
$219M
| $388K | ﹤0.01% |
24,245
| – | – |
|
|
ZYXI
3042
DELISTED
Zynex
ZYXI
| $387K | ﹤0.01% |
67,003
+521
| +0.8% | +$3.66K |
|
3043
Humacyte
HUMA
$194M
| $382K | ﹤0.01% |
+60,587
| New | +$353K |
|
3044
Tarsus Pharmaceuticals
TARS
$2.84B
| $381K | ﹤0.01% |
21,763
| – | – |
|
3045
SAP
SAP
$238B
| $378K | ﹤0.01% |
3,409
-66,196
| -95% | -$8.05M |
|
|
ME
3046
DELISTED
23andMe Holding Co
ME
| $377K | ﹤0.01% |
+5,272
| New | +$481K |
|
|
DOYU
3047
DouYu International Holdings
DOYU
$142M
| $375K | ﹤0.01% |
18,012
-108,500
| -86% | -$2.39M |
|
|
TEAD
3048
Teads Holding Co
TEAD
$66.9M
| $375K | ﹤0.01% |
+33,575
| New | +$422K |
|
|
LENZ
3049
LENZ Therapeutics
LENZ
$168M
| $373K | ﹤0.01% |
7,744
+4,380
| +130% | +$274K |
|
|
SQZ
3050
DELISTED
SQZ Biotechnologies Company
SQZ
| $370K | ﹤0.01% |
77,754
+1,347
| +2% | +$8.55K |
|
Similar funds
VFT
Nuveen's Q1 2022 Portfolio in Review
As of Q1 2022, Nuveen held 3,477 positions worth $309B, down 8.7% from $338B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Nuveen's Q1 2022 filing shows 138 new, 1,588 increased, 1,481 reduced and 89 closed positions. Its largest new stake was Constellation Energy: 1,208,173 shares worth $59.5M. The largest sale was Qualcomm, an estimated $712M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.
- Nuveen's largest Q1 2022 buy was Constellation Energy: 1,208,173 shares worth $59.5M.
- Nuveen added most to Advanced Micro Devices in Q1 2022, an estimated $949M increase.
- Nuveen's biggest Q1 2022 reduction was Qualcomm, cutting an estimated $712M.
- Nuveen fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $264M.
- Nuveen's ten largest holdings make up 23% of its $309B portfolio in Q1 2022.
- Nuveen opened 138 new positions and closed 89 in Q1 2022.
- Nuveen's portfolio value fell 8.7% quarter-over-quarter to $309B.
Based on Nuveen's 13F filing for Q1 2022, filed 16 May 2022.